Despite their potential benefits to the disease course, careful attention should be given when GLP-1 RAs are used in IBD patients since their most common side effects involve the gastrointestinal tract, with nausea, vomiting, diarrhoea, and constipation being the most frequently reported [62,63]. Here, GCG is linked to inflammatory bowel disease.